Treatment of bipolar I disorder in an adolescent with olanzapine

被引：13
|
作者：
Khouzam, HR
El-Gabalawi, F
机构：
[1] VA Med Ctr, Dept Psychiat, Manchester, NH 03104 USA
[2] Dartmouth Med Sch, Dept Psychiat, Lebanon, NH USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[4] Albert Einstein Med Ctr, Inpatient Adolescent Unit, Belmont Ctr, Philadelphia, PA 19141 USA
[5] Thomas Jefferson Univ Hosp, Dept Psychiat, Philadelphia, PA 19107 USA
[6] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA
[7] Thomas Jefferson Univ, Div Child & Adolescent Psychiat, Philadelphia, PA USA
来源：
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 2000年 / 10卷 / 02期
关键词：
D O I：
10.1089/cap.2000.10.147
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Bipolar I disorder is estimated to affect 0.6% of adolescents, Lithium, sodium valproate, carbamazapine, and adjunctive treatment with benzodiazapines and antipsychotics have been used to treat bipolar I disorders. We report a case of a 17-year-old adolescent male with bipolar I disorder who responded favorably to the treatment with the atypical antipsychotic olanzapine, We hypothesize that olanzapine's broad affinity for both dopaminergic and serotonergic receptors may be related to the beneficial therapeutic outcome.
引用
收藏
页码：147 / 151
页数：5
相关论文
共 50 条
  • [1] Olanzapine in the treatment of bipolar disorder
    Krueger, Stephanie
    PSYCHIATRISCHE PRAXIS, 2006, 33 : S18 - S26
  • [2] Safety of the novel antipsychotic olanzapine in the treatment of bipolar I disorder
    Tohen, M
    Jacobs, T
    Gannon, KS
    Sanger, T
    Greaney, M
    Breier, A
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 193 - 193
  • [3] Olanzapine - A review of its use in the treatment of bipolar I disorder
    Bhana, N
    Perry, CM
    CNS DRUGS, 2001, 15 (11) : 871 - 904
  • [4] Spotlight in olanzapine in bipolar I disorder
    McCormack, PL
    Wiseman, LR
    CNS DRUGS, 2005, 19 (06) : 553 - 555
  • [5] Spotlight on Olanzapine in Bipolar I Disorder
    Paul L. McCormack
    Lynda R. Wiseman
    CNS Drugs, 2005, 19 : 553 - 555
  • [6] Vitamin E Treatment for Olanzapine Induced Tardive Dyskinesia in an Adolescent with Bipolar Disorder
    Tufan, Ali Evren
    Yalug, Irem
    Bilici, Rabia
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 23 (02): : 190 - 192
  • [7] Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
    Maloney, Ann E.
    Sikich, Linmarie
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 749 - 766
  • [8] Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling
    Sanger, TM
    Tohen, M
    Vieta, E
    Dunner, DL
    Bowden, CL
    Calabrese, JR
    Feldman, PD
    Jacobs, TG
    Breier, A
    JOURNAL OF AFFECTIVE DISORDERS, 2003, 73 (1-2) : 155 - 161
  • [9] Olanzapine In Adolescents with Schizophrenia or Bipolar I Disorder
    McCormack, Paul L.
    CNS DRUGS, 2010, 24 (05) : 443 - 452
  • [10] Olanzapine/Samidorphan: A New Option for the Treatment of Adults With Schizophrenia or Bipolar I Disorder
    Huy Pham
    Warlick, Halford
    Bermudez, Ricardo
    Quan Nguyen
    Rey, Jose A.
    JOURNAL OF PHARMACY TECHNOLOGY, 2022, 38 (05) : 304 - 313
12345